4//SEC Filing
Chan Gerald 4
Accession 0001127602-24-000114
CIK 0001492422other
Filed
Jan 1, 7:00 PM ET
Accepted
Jan 2, 4:10 PM ET
Size
7.0 KB
Accession
0001127602-24-000114
Insider Transaction Report
Form 4
Chan Gerald
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-01-01$59.86/sh+5,748$344,075→ 5,748 totalExercise: $59.86Exp: 2030-12-31→ Common Stock (5,748 underlying) - Award
Common Stock
2024-01-01+3,341→ 11,438 total
Footnotes (2)
- [F1]This restricted stock unit was granted on January 1, 2024. The restricted stock unit will fully vest on the first anniversary of the date of grant, subject to his continued service as a director, or upon later termination of his service as a director at his election.
- [F2]This option was granted on January 1, 2024. The option vests quarterly on the last day of each quarter from the date of grant, subject to his continued service as a director and expires seven years after the date of grant.
Documents
Issuer
Apellis Pharmaceuticals, Inc.
CIK 0001492422
Entity typeother
Related Parties
1- filerCIK 0001636579
Filing Metadata
- Form type
- 4
- Filed
- Jan 1, 7:00 PM ET
- Accepted
- Jan 2, 4:10 PM ET
- Size
- 7.0 KB